Biggest changeFiscal Years Ended January 1, 2023 December 26, 2021 December 27, 2020 December 29, 2019 December 31, 2018 (dollars in thousands, except per share data) Statement of Operations Data: Revenues $ 298,422 $ 239,027 $ 207,125 $ 219,764 $ 206,174 Gross profit $ 103,548 $ 80,941 $ 66,040 $ 69,826 $ 64,520 Selling, general and administrative expenses $ 83,211 $ 65,115 $ 55,244 $ 50,222 $ 44,787 Gain on contingent consideration $ — $ (2,403) $ (76) $ — $ (3,775) Impairment losses $ — $ — $ 7,240 $ — $ — Depreciation and amortization $ 4,054 $ 3,698 $ 4,861 $ 4,718 $ 4,833 Operating income (loss) $ 16,283 $ 14,531 $ (1,229) $ 14,886 $ 18,675 Loss on extinguishment of debt $ — $ — $ — $ 541 $ — Interest expense, net $ 1,363 $ 1,433 $ 1,584 $ 1,569 $ 2,850 Income (loss) from continuing operations before income taxes $ 14,920 $ 13,098 $ (2,813) $ 12,776 $ 15,825 Income tax expense (benefit) from continuing operations $ 3,659 $ 2,640 $ (741) $ 3,135 $ 2,855 Income (loss) from continuing operations $ 11,261 $ 10,458 $ (2,072) $ 9,641 $ 12,970 Income from discontinued operations, net of tax $ 14,100 $ 3,651 $ 3,513 $ 3,606 $ 4,579 Net income $ 25,361 $ 14,109 $ 1,441 $ 13,247 $ 17,549 Basic income (loss) per share: Continuing operations $ 1.08 $ 1.01 $ (0.20) $ 0.94 $ 1.35 Income from discontinued operations: Income 0.12 0.44 0.46 0.46 0.58 Gain on Sale 1.69 — — — — Income tax expense (0.46) (0.09) (0.12) (0.11) (0.10) Net income per share – basic $ 2.43 $ 1.36 $ 0.14 $ 1.29 $ 1.83 Diluted income (loss) per share: Continuing operations $ 1.07 $ 1.00 $ (0.20) $ 0.93 $ 1.32 Income from discontinued operations: Income 0.12 0.44 0.46 0.46 0.57 Gain on Sale 1.69 — — — — Income tax expense (0.46) (0.09) (0.12) (0.11) (0.10) Net income per share – diluted $ 2.42 $ 1.35 $ 0.14 $ 1.28 $ 1.79 25 Weighted average shares outstanding – basic 10,427 10,367 10,312 10,239 9,577 Weighted average shares outstanding – diluted 10,473 10,417 10,338 10,351 9,808 Other Financial Data: Adjusted EBITDA from continuing operations (1) $ 21,693 $ 14,970 $ 12,197 $ 21,609 $ 21,256 Cash dividends declared per common share $ 0.60 $ 0.44 $ 0.50 $ 1.20 $ 1.15 Balance Sheet Data from Continuing Operations: Working capital $ 47,955 $ 25,851 $ 17,960 $ 20,532 $ 13,079 Total assets $ 194,673 $ 148,294 $ 130,278 $ 100,378 $ 84,316 Total outstanding borrowings, net $ 66,670 $ 39,450 $ 34,634 $ 27,494 $ 20,089 Total other long-term liabilities $ 3,059 $ 7,240 $ 14,224 $ 6,068 $ 654 Stockholders’ equity $ 100,737 $ 76,592 $ 65,458 $ 68,457 $ 65,702 (1) We present Adjusted EBITDA (defined below), a measure that are not in accordance with accounting principles generally accepted in the United States of America (“non-GAAP”), in this Annual Report on Form 10-K to provide investors with a supplemental measure of our operating performance.
Biggest changeThe statement of operations data for the fiscal years ended 2021 and 2020 and the balance sheet data as of January 1, 2023, December 26, 2021, and December 27, 2020 set forth below were derived from our audited financial statements not included in this Annual Report on Form 10-K. 25 Fiscal Years Ended December 29, 2024 December 31, 2023 January 1, 2023 December 26, 2021 December 27, 2020 (dollars in thousands, except per share data) Statement of Operations Data: Revenues $ 272,499 $ 313,167 $ 298,422 $ 239,027 $ 207,125 Gross profit $ 92,863 $ 111,784 $ 103,548 $ 80,941 $ 66,040 Selling, general, and administrative expenses $ 85,333 $ 88,650 $ 83,211 $ 65,116 $ 55,244 Gain on contingent consideration $ (1,452) $ — $ — $ (2,403) $ (76) Impairment losses $ — $ 22,545 $ — $ — $ 7,240 Depreciation and amortization $ 7,769 $ 7,774 $ 4,054 $ 3,698 $ 4,861 Operating income (loss) $ 1,213 $ (7,185) $ 16,283 $ 14,530 $ (1,229) Interest expense, net $ (4,921) $ (5,976) $ (1,363) $ (1,433) $ (1,584) (Loss) income before income taxes from continuing operations $ (3,708) $ (13,161) $ 14,920 $ 13,097 $ (2,813) Income tax benefit (expense) from continuing operations $ 370 $ 2,938 $ (3,659) $ (2,639) $ 741 (Loss) income from continuing operations $ (3,338) $ (10,223) $ 11,261 $ 10,458 $ (2,072) Income from discontinued operations, net of tax $ — $ — $ 14,100 $ 3,651 $ 3,513 Net (loss) income $ (3,338) $ (10,223) $ 25,361 $ 14,109 $ 1,441 Net (loss) income per share - basic: Continuing operations $ (0.31) $ (0.95) $ 1.08 $ 1.01 $ (0.20) Income from discontinued operations: Income — — 0.12 0.44 0.46 Gain on Sale — — 1.69 — — Income tax expense — — (0.46) (0.09) (0.12) Net (loss) income per share – basic $ (0.31) $ (0.95) $ 2.43 $ 1.36 $ 0.14 Net (loss) income per share - diluted: Continuing operations $ (0.31) $ (0.95) $ 1.07 $ 1.00 $ (0.20) Income from discontinued operations: Income — — 0.12 0.44 0.46 Gain on Sale — — 1.69 — — Income tax expense — — (0.46) (0.09) (0.12) Net (loss) income per share – diluted $ (0.31) $ (0.95) $ 2.42 $ 1.35 $ 0.14 Weighted average shares outstanding – basic 10,896 10,766 10,427 10,367 10,312 Weighted average shares outstanding – diluted 10,896 10,766 10,473 10,417 10,338 26 Fiscal Years Ended December 29, 2024 December 31, 2023 January 1, 2023 December 26, 2021 December 27, 2020 (dollars in thousands, except per share data) Other Financial Data: Adjusted EBITDA from continuing operations (1) $ 10,475 $ 25,858 $ 22,353 $ 15,288 $ 12,350 Same Day EBITDA from continuing operations (1) $ 10,475 $ 25,858 $ 21,943 $ 15,288 $ 12,350 Cash dividends declared per common share $ 0.15 $ 0.60 $ 0.60 $ 0.44 $ 0.50 Balance Sheet Data from Continuing Operations: Working capital (2) $ 19,427 $ (18,144) $ 47,955 $ 25,851 $ 17,960 Total assets $ 150,111 $ 178,517 $ 194,673 $ 148,294 $ 130,278 Total outstanding borrowings, net $ 46,321 $ 63,114 $ 66,671 $ 39,450 $ 34,634 Total other long-term liabilities $ 3,770 $ 7,926 $ 3,059 $ 7,240 $ 14,224 Stockholders’ equity $ 82,269 $ 85,536 $ 100,736 $ 76,592 $ 65,458 (1) We present Adjusted EBITDA and Same Day EBITDA (defined below), measure that are not in accordance with accounting principles generally accepted in the United States of America (“non-GAAP”), in this Annual Report on Form 10-K to provide investors with a supplemental measure of our operating performance.
Our board and management also use Adjusted EBITDA as one of the primary methods for planning and forecasting overall expected performance and for evaluating on a quarterly and annual basis actual results against such expectations, and as a performance evaluation metric in determining achievement of certain compensation programs and plans for our management.
Our board and management also use Adjusted EBITDA and Same Day EBITDA as one of the primary methods for planning and forecasting overall expected performance and for evaluating on a quarterly and annual basis actual results against such expectations, and as a performance evaluation metric in determining achievement of certain compensation programs and plans for our management.
Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items.
Our presentation of Adjusted EBITDA and Same Day EBITDA should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items.
We believe that Adjusted EBITDA is a useful performance measures and is used by us to facilitate a comparison of our operating performance on a consistent basis from period-to-period and to provide for a more complete understanding of factors and trends affecting our business than measures under accounting principles generally accepted in the United States of America (“GAAP”) can provide alone.
We believe that Adjusted EBITDA and Same Day EBITDA are useful performance measures and are used by us to facilitate comparisons of our operating performance on a consistent basis from period-to-period and to provide for a more complete understanding of factors and trends affecting our business than measures under accounting principles generally accepted in the United States of America (“GAAP”) can provide alone.
(2) In the Professional segment, we recognized a $3.7 million trade name impairment loss and a $3.5 million client partner list impairment loss during the thirteen week period ended June 28, 2020. 27
(2) In the Professional segment, we recognized a $3.7 million trade name impairment loss and a $3.5 million client partner list impairment loss during the thirteen week period ended June 28, 2020. We recognized a $22.5 million trade name impairment loss during the thirteen week period ended April 2, 2023.
Adjusted EBITDA should not be considered as an alternative to net income for the periods indicated as a measure of our performance. Other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.
Same Day EBITDA should not be considered as an alternative to net income for the periods indicated as a measure of our performance. Other companies in our industry may calculate Adjusted EBITDA or Same Day EBITDA differently than we do, limiting their usefulness as comparative measures.
The statement of operations data for the fiscal years ended 2022, 2021, and 2020 and the balance sheet data as of January 1, 2023 and December 26, 2021 set forth below are derived from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
The statement of operations data for the fiscal years ended 2024, 2023, and 2022 and the balance sheet data as of December 29, 2024 and December 31, 2023 set forth below are derived from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
The use of Adjusted EBITDA has limitations as analytical tool, and you should not consider this performance measure in isolation from, or as an alternative to, GAAP measures such as net income. Adjusted EBITDA is not a measure of liquidity under GAAP or otherwise, and is not an alternative to cash flow from continuing operating activities.
The use of Adjusted EBITDA and Same Day EBITDA have limitations as analytical tools, and you should not consider these performance measure in isolation from, or as an alternative to, GAAP measures such as net income.
Fiscal Years Ended January 1, 2023 December 26, 2021 December 27, 2020 December 29, 2019 December 31, 2018 (dollars in thousands) Net income (loss) from continuing operations $ 11,261 $ 10,458 $ (2,072) $ 9,641 $ 12,970 Income tax expense (benefit) from continuing operations (1) 3,659 2,640 (741) 3,135 2,855 Interest expense, net 1,363 1,433 1,584 1,569 2,850 Loss on extinguishment of debt — — — 541 — Operating income (loss) 16,283 14,531 (1,229) 14,886 18,675 Depreciation and amortization 4,054 3,698 4,861 4,718 4,833 Gain on contingent consideration — (2,403) (76) — (3,775) Impairment losses (2) — — 7,240 — — CARES Act credit — (2,084) — — — Share-based compensation 1,085 1,058 786 850 1,015 Transaction fees 271 170 615 434 508 Adjusted EBITDA from continuing operations 21,693 14,970 12,197 20,888 21,256 (1) 2020 Included a $3.3 million re-measurement of the net deferred tax assets as a result of the TCJA.
Fiscal Years Ended December 29, 2024 December 31, 2023 January 1, 2023 December 26, 2021 December 27, 2020 (dollars in thousands) (Loss) income from continuing operations $ (3,338) $ (10,223) $ 11,261 $ 10,458 $ (2,072) Income tax (benefit) expense from continuing operations (1) (370) (2,938) 3,659 2,639 (741) Interest expense, net 4,921 5,976 1,363 1,433 1,584 Operating income (loss) 1,213 (7,185) 16,283 14,530 (1,229) Depreciation and amortization 7,769 7,774 4,054 3,698 4,861 Gain on contingent consideration (1,452) — — (2,403) (76) Impairment losses (2) — 22,545 — — 7,240 CARES Act credit — — — (2,084) — Share-based compensation 989 1,029 1,085 1,058 786 Strategic alternatives review 962 — — — — Cost restructuring plan 230 — — — — Software as a service (3) 716 720 660 319 153 Transaction fees 48 975 271 170 615 Adjusted EBITDA from continuing operations 10,475 25,858 22,353 15,288 12,350 Same day adjustment — — (410) — — Same day EBITDA from continuing operations $ 10,475 $ 25,858 $ 21,943 $ 15,288 $ 12,350 (1) 2020 Included a $3.3 million re-measurement of the net deferred tax assets as a result of the TCJA.
In addition, the financial covenants in our credit agreement are based on EBITDA as defined in the credit agreement. We define “Adjusted EBITDA” as earnings before interest expense, income taxes, depreciation and amortization expense, impairment losses, transaction fees, and certain non-cash expenses such as share-based compensation expense.
We define “Adjusted EBITDA” as earnings before interest expense, income taxes, depreciation and amortization expense, impairment losses, costs associated with the evaluation of potential strategic alternatives (“Strategic alternatives review”), transaction fees, software as a service costs, and certain non-cash expenses such as share-based compensation expense.
The limitations of Adjusted EBITDA include: (i) it does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments; (ii) it does not reflect changes in, or cash requirements for, our working capital needs; (iii) it does not reflect income tax payments we may be required to make; and (iv) it does not reflect the cash requirements necessary to service interest or principal payments associated with indebtedness. 26 To properly and prudently evaluate our business, we encourage you to review our consolidated financial statements included elsewhere in this Annual Report on Form 10-K and the reconciliation to Adjusted EBITDA from net income, the most directly comparable financial measure presented in accordance with GAAP, set forth in the following table.
To properly and prudently evaluate our business, we encourage you to review our consolidated financial statements included elsewhere in this Annual Report on Form 10-K and the reconciliation to Adjusted EBITDA and Same Day EBITDA from net (loss) income, the most directly comparable financial measure presented in accordance with GAAP, set forth in the following table.